Endo: Type 2 Diabetes Mellitus: Free MSRA Podcast

🎧 Podcast Episode: Type 2 Diabetes Mellitus – Revision Deep Dive for MSRAWelcome back to another episode of The Deep Dive, where today we focus on one of the most important and high-yield conditions in endocrinology: Type 2 Diabetes Mellitus (T2DM) 🩸⚖️This episode gives you a comprehensive yet digestible breakdown of what you need to know for the MSRA exam – and clinical practice. Let's make insulin resistance stick! 💉📚 What You’ll Learn in This Episode:• 🔍 Definition: A chronic metabolic disorder marked by insulin resistance and relative insulin deficiency, leading to hyperglycaemia.• 🧬 Pathophysiology: Starts with insulin resistance → progresses to β-cell dysfunction → rising glucose levels.• ⚠️ Causes/Risk Factors:Mnemonic: OBESITY-FAMED DEALObesity (central)Ethnicity (e.g. South Asian, African Caribbean)Sedentary lifestyleIncreasing AgeFamily HistoryPCOSDrugs (e.g. steroids, thiazides)Gestational diabetes, Metabolic syndromeLow birthweight• 💡 Symptoms:The 3 Ps: Polyuria, Polydipsia, PolyphagiaFatigue, blurred vision, recurrent infectionsSlow wound healingOften asymptomatic early on• 🧪 Diagnosis:Fasting glucose ≥ 7.0 mmol/LHbA1c ≥ 48 mmol/mol (6.5%)OGTT: 2h glucose ≥ 11.1 mmol/LNote: HbA1c is unreliable in some conditions (e.g. hemoglobinopathies, anaemia, pregnancy)• 🩺 Differentials Mnemonic: LTSLADA (latent autoimmune diabetes in adults)Type 1 diabetesSecondary causes (e.g. Cushing’s, pancreatitis, steroid use)• 📊 Epidemiology:Accounts for 90% of all diabetes casesRising prevalence in younger populations due to obesityOften underdiagnosed🧠 Management Summary:• 🍎 Lifestyle is the cornerstone: diet, physical activity, weight loss• 💊 Medications:First-line = MetforminSGLT2 inhibitors (e.g. empagliflozin) for cardiovascular/renal protectionGLP-1 agonists, DPP-4 inhibitors, sulfonylureas, insulin depending on control & comorbidities• 🎯 HbA1c Targets:General: ≤48 mmol/mol (6.5%) if on lifestyle/metforminRelaxed: ≤53 mmol/mol (7.0%) if risk of hypos• 🔄 Review every 3–6 months, depending on stability and treatment changes• 🩺 Additional Management:Blood pressure (target <140/90 mmHg; lower if organ damage)Statins for most adults with T2DMCardiovascular risk assessmentRetinal screening, foot checks, kidney monitoring• 📉 Complication Prevention: Essential to reduce macrovascular (MI, stroke) and microvascular (retinopathy, nephropathy, neuropathy) risks🚨 Complications:• Acute:HHS (Hyperosmolar Hyperglycaemic State)DKA (less common in T2DM)• Chronic:Macrovascular: MI, stroke, PADMicrovascular: Retinopathy, nephropathy, neuropathyInfections and poor wound healing → foot ulcers, amputation📝 Top Mnemonics Recap:• OBESITY-FAMED DEAL – Risk factors• 3 P’s – Symptoms• LTS – Differentials📚 MSRA Learning Resources:🗂️ Revision Noteshttps://www.passthemsra.com/topic/diabetes-mellitus-type-2-revision-notes/🧠 Flashcardshttps://www.passthemsra.com/topic/diabetes-mellitus-type-2-flashcards/❓ Accordion Q&Ahttps://www.passthemsra.com/topic/diabetes-mellitus-type-2-accordion-qa-notes/🔥 Rapid Quizhttps://www.passthemsra.com/topic/diabetes-mellitus-type-2-rapid-quiz/🧪 Bonus Quizhttps://www.passthemsra.com/quizzes/diabetes-mellitus-type-2/🎯 Final Takeaway:Type 2 Diabetes Mellitus is a progressive, lifestyle-linked metabolic condition. With early diagnosis, individualised care, and aggressive cardiovascular risk management, complications can be prevented and outcomes vastly improved. This isn’t just an exam topic – it’s clinical core knowledge. 🏥💡#MSRA #Type2Diabetes #Endocrinology #MSRARevision #DiabetesPodcast #Hyperglycaemia #Metformin #SGLT2 #HbA1c #MedicalEducation #MSRAFlashcards #MSRAQuestionBank #MedicalPodcast #TheDeepDive